# US 2010/0168823 A1 · Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168823 A1
- Document ID: US20100168823A1
- Status: Published application
- Kind: A1
- Application number: 12/648,113
- Filed: 2009-12-28
- Published: 2010-07-01
- Earliest claimed: 2004-02-09
- Inventors: John Strisower
- Web page: https://patentgrep.com/patent/US20100168823A1

## CPC

- A61M 1/3681: {by irradiation}
- A61B 5/0084: {for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence)}
- A61N 5/0601: {Apparatus for use inside the body}
- A61N 5/0624: {for eliminating microbes, germs, bacteria on or in the body}
- A61M 2205/053: ultraviolet
- A61N 2005/0604: {Lungs and/or airways}
- A61N 2005/0661: {ultraviolet}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Method and apparatus for using computer controlled, fiber-coupled laser delivery of treatment specific wavelength, intensity and duration of UV irradiation to control bacterial, fungal, viral and mold infections in bodily cavities, fluids and external applications. The method of treatment is focused on DNA breakdown beyond repair by natural DNA repair mechanisms of the pathogen, with less than damaging doses to tissues being treated, thus avoiding mutagenicity and carcinogenicity. The minimal intensity and duration and exposure area of any given surface of tissue to be treated is to be pre-determined by tissue and pathogen testing to optimize the therapeutic ratio. External applications include specifically Trichophyton Rubrum (toenail fungus) through the nail and Pseudomonas Aeruginosa infections in burns and elsewhere.

## Claims

### Claim 1

An apparatus comprising:
a laser for providing irradiation in the ultraviolet spectrum;
a computer controller coupled to the laser;
an optical fiber coupled to the laser to transmit the ultraviolet irradiation; and
a tube attached to one end of the optical fiber, wherein the optical fiber delivers the ultraviolet irradiation into the tube so as to irradiate a patient's blood or bodily fluids flowing through the tube, the blood or bodily fluids including pathogens therein;
the computer controller setting at least one of the duration, wavelength(s) or intensity of ultraviolet irradiation to be applied by the laser to deactivate the DNA of the pathogens.

### Claim 2 (depends on 1)

The apparatus of claim 1 wherein the tube is configured to be placed within the patient's body inline to an artery or other bodily fluidic passage.

### Claim 3 (depends on 2)

The apparatus of claim 2 wherein the pathogens comprise one or more of bacteria, virus or fungus.

### Claim 4 (depends on 1)

The apparatus of claim 1 wherein the tube is configured to be placed external to the patient's body with the blood or other bodily fluids diverted to flow through the tube.

### Claim 5 (depends on 4)

The apparatus of claim 4 wherein the pathogens comprise one or more of bacteria, virus or fungus.

### Claim 6

An apparatus comprising:
a laser for providing irradiation in the ultraviolet spectrum;
a computer controller coupled to the laser; and
an optical fiber coupled to the laser to transmit and deliver the ultraviolet irradiation to one or more toenails, the one or more toenails including Trichophyton Rubrum thereon; and
the computer controller causing the laser to deliver the ultraviolet irradiation with at least one of a duration, wavelength(s) or intensity sufficient to treat the Trichophyton Rubrum with minimal damage to surrounding tissue of said one or more toenails.

### Claim 7 (depends on 6)

The apparatus of claim 6 wherein the minimal damage to surrounding tissue of said one or more toenails includes avoiding mutagenicity and carcinogenicity.

### Claim 8 (depends on 6)

The apparatus of claim 6 wherein treating the Trichophyton Rubrum includes deactivating the DNA of the Trichophyton Rubrum.

### Claim 9

An apparatus comprising:
a laser for providing irradiation in the ultraviolet spectrum;
a computer controller coupled to the laser;
an optical fiber coupled to the laser to transmit and deliver the ultraviolet irradiation to one or more areas of a patient's skin, said one or more areas of the patient's skin including Pseudomonas Aeruginosa thereon; and
the computer controller causing the laser to deliver the ultraviolet irradiation with at least one of a duration, wavelength(s) or intensity sufficient to treat the Pseudomonas Aeruginosa with minimal damage to surrounding tissue of said one or more areas of a patient's skin.

### Claim 10 (depends on 9)

The apparatus of claim 9 wherein the minimal damage to surrounding tissue of said one or more areas of a patient's skin includes avoiding mutagenicity and carcinogenicity.

### Claim 11 (depends on 9)

The apparatus of claim 9 wherein treating the Pseudomonas Aeruginosa includes deactivating the DNA of the Pseudomonas Aeruginosa.

### Claim 12 (depends on 11)

The apparatus of claim 11 wherein the one or more areas of the patient's skin contain burn wounds infected by Pseudomonas Aeruginosa.

### Claim 13

A method comprising:
diagnosing a type of a pathogen infecting bodily fluids in a human patient;
selecting UV irradiation parameters comprising at least one of the duration, wavelength(s) or intensity to deactivate the DNA of the pathogen but below a threshold for minimal damage to the bodily fluids; and
delivering the UV irradiation with the selected parameters through a fiber-coupled laser apparatus controlled by a computer regulated routine so as to deactivate the DNA of a pathogen in the tissue.

### Claim 14 (depends on 13)

The method of claim 13 wherein the pathogen comprises one or more of bacteria, virus or fungus.

### Claim 15

A method comprising:
diagnosing a type of a pathogen infecting a tissue in one or more areas on the exterior of a human body;
selecting UV irradiation parameters comprising at least one of the duration, wavelength(s) or intensity to deactivate the DNA of the pathogen but below a threshold for minimal damage to the tissue; and
delivering the UV irradiation with the selected parameters through a fiber-coupled laser apparatus controlled by a computer regulated routine so as to deactivate the DNA of a pathogen in the tissue.

### Claim 16 (depends on 15)

The method of claim 15 wherein the minimal damage to the tissue includes avoiding mutagenicity and carcinogenicity.

### Claim 17 (depends on 15)

The method of claim 15 wherein the pathogen comprises one or more of bacteria, virus or fungus.

### Claim 18 (depends on 15)

The method of claim 15 wherein the pathogen is Trichophyton Rubrum.

### Claim 19 (depends on 15)

The method of claim 15 wherein the pathogen is Pseudomonas Aeruginosa.

### Claim 20

A method comprising:
diagnosing the type of a pathogen infecting a tissue in the lung of a human or animal;
opening the airways inside the lung by using doped perfluorocarbons in a liquid ventilation or partial liquid ventilation process in the lung;
selecting UV irradiation parameters comprising at least one of a duration, wavelength(s) or intensity to deactivate the DNA of the pathogen but below a threshold for minimal damage to the tissue;
delivering UV irradiation with the selected parameters transmitted by a fiber-coupled laser apparatus so as to deactivate the DNA of a pathogen in the tissue; and
the doped perfluorocarbons selected for optical properties to refract or reflect the UV irradiation.

### Claim 21 (depends on 20)

The method of claim 20 wherein the fiber-coupled laser apparatus is controlled by a computer regulated routine.

### Claim 22 (depends on 20)

The method of claim 20 wherein the liquid ventilation or partial liquid ventilation process further comprises antibiotics with the doped perfluorocarbons.

### Claim 23 (depends on 20)

The method of claim 20 wherein the liquid ventilation or partial liquid ventilation process further comprises retrovirus carrying DNA for gene therapy with the doped perfluorocarbons.

### Claim 24 (depends on 20)

The method of claim 20 wherein the minimal damage to the tissue includes avoiding mutagenicity and carcinogenicity.
